Hualan Biological: Announcement on the resignation of independent directors, the re-election of independent directors of the 9th Board of Directors, and the adjustment of members of the Board's special committees

If you’re trading stocks, just look at analysis reports from the Jin Qilin analyst team—authoritative, professional, timely, and comprehensive. Help you uncover high-potential themes and opportunities!

Announcement of Hualan Bio-Engineering Co., Ltd. on the Resignation of an Independent Director, the Election of an Independent Director to the Ninth Board of Directors, and the Adjustment of Members of the Board’s Special Committees

I. Details on the Resignation of the Independent Director Hualan Bio-Engineering Co., Ltd. (hereinafter referred to as the “Company”)’s board of directors has recently received a written resignation report submitted by Ms. Liu Wanli, an independent director of the Company. Ms. Liu Wanli has served consecutively as an independent director of the Company, which will be

approaching the six-year mark. In accordance with relevant regulatory requirements such as the “Administrative Measures for Independent Directors of Listed Companies,” Ms. Liu Wanli

applies to resign from her positions as an independent director of the Company’s Ninth Board of Directors and as a member of the relevant special committees of the board. According to relevant laws and regulations, Ms. Liu Wanli’s resignation report will become effective after the general meeting elects a new independent director.

II. Details on the Supplementary Election of an Independent Director to the Ninth Board of Directors of the Company The Company convened the First Meeting of the Nomination Committee of the Ninth Board of Directors in 2026 on March 27, 2026. The

and

day, the Fourth Meeting of the Ninth Board of Directors was held on

, at which time the motion titled “Proposal on the Supplementary Election of an Independent Director to the Ninth Board of Directors” was deliberated and approved. The board deliberated and approved Ms. Liu Yongli as an independent director of the Company’s Ninth Board of Directors (for her resume, see the attachment). The term shall run from the date the general meeting approves the election until the date the term of the Ninth Board of Directors expires.

Ms. Liu Yongli’s qualifications and independence still need to be reviewed and deemed without objection by the Shenzhen Stock Exchange before she may submit the matter for deliberation by the general meeting.

III. Details on the Adjustment of Members of the Special Committees of the Ninth Board of Directors of the Company After Ms. Liu Wanli’s resignation as an independent director becomes effective, the vacancies in each of the Ninth Board of Directors’ special committees (members of the audit committee and the remuneration and performance evaluation committee) will be filled by Ms. Liu Wanli. Given that Ms. Liu Wanli is currently a candidate for independent director and has not yet been elected as an independent director, this matter still requires approval by the general meeting of the “Proposal on the Supplementary Election of an Independent Director to the Ninth Board of Directors” in order to become effective; the committee members’ term shall run from the date the general meeting approves the matter until the date the term of the Ninth Board of Directors expires.

After the adjustment takes effect, the personnel composition of each special committee of the Ninth Board of Directors is as follows:

Name of special committee Members Convenor (Chairman) Strategy Committee An Kang, Fan Pei, Su Zhiguo An Kang Remuneration and Performance Evaluation Committee Su Zhiguo, Liu Wanli, An Wenjie Su Zhiguo Nomination Committee Su Zhiguo, Zhang Zhiqian, An Wenqi Su Zhiguo Audit Committee Liu Wanli, Zhang Zhiqian, Pan Ruowen Liu Wanli

IV. Documents for Reference

1. Resolution of the Fourth Meeting of the Ninth Board of Directors of the Company; 2. Resolution of the First Meeting of the Nomination Committee of the Ninth Board of Directors of the Company in 2026. This announcement is hereby issued.

Board of Directors of Hualan Bio-Engineering Co., Ltd.

2026

month

day

Attachment:

Resume of Ms. Liu Wanli Ms. Liu Wanli: Female, born in 1977, Chinese national, no overseas permanent residence rights, PhD degree. She graduated from Henan University of Finance and Economics in June 1998 with a major in accounting, and obtained a bachelor’s degree. From September 2005 to June 2008, she studied for a master’s degree in business administration at Xi’an University of Technology. She obtained a master’s degree. From 2009

to 2013

, she studied accounting at Huazhong University of Science and Technology and obtained a PhD degree. From January 2001 to August 2009, she worked in the finance department of Zhengzhou Education Foreign Exchange Service Center, serving as an accounting supervisor; from July 2013 to April 2024, she served as a lecturer and vice professor at the Business School of Zhengzhou University of Aeronautical Industry Management. She currently serves as a professor at the Business School of Zhengzhou University of Aeronautical Industry Management, an independent director of AVIC Optoelectronics Technology Co., Ltd., and an independent director of Hengyu Xintong Aviation Equipment (Beijing) Co., Ltd. As of the date of this announcement, Ms. Liu Wanli does not hold any shares of the Company, and there is no relationship with other shareholders holding more than 5% of the Company’s shares, the actual controller, other directors, or senior management personnel. She has not received any penalties from the China Securities Regulatory Commission or other relevant authorities, nor any disciplinary sanctions from the securities exchange. She has not been filed by judicial authorities for investigation on suspicion of a crime, nor has she been placed on record for investigation by the China Securities Regulatory Commission due to suspicion of violations or irregularities without an explicit conclusion. She has not been publicly listed on the securities and futures market violation-and-default information disclosure inquiry platform by the China Securities Regulatory Commission, nor has she been included in the list of persons subjected to enforcement by the people’s courts for trust-breaking. There are no circumstances listed in Article 3.2.2 of the “Guidelines for Self-Regulation of Listed Companies No. 1—Standardized Operation of Main Board Listed Companies,” and she meets the appointment conditions stipulated in the “Company Law of the People’s Republic of China” and the “Articles of Association of the Company.”

Statement: The market has risk; investing requires caution. This article is automatically published based on third-party databases and does not represent Sina Finance’s viewpoints. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there is any discrepancy, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

Massive information and precise analysis—available on the Sina Finance App

Responsible editor: Xiao Lang Express